Intelligent wearable device for early recognition and alarm of phlebitis and drug extravasation

Through the smart wearable device monitoring the temperature, pressure and color data of the puncture site in real time, calculating the risk index and alarm, the problem of the inability to identify and alarm in the existing technology in the early stage is solved, and the treatment safety and effectiveness are improved.

CN119073906APending Publication Date: 2024-12-06BEIJING CANCER HOSPITAL PEKING UNIV CANCER HOSPITAL
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411108524.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing phlebitis and drug extravasation recognition devices cannot evaluate the puncture of veins in real time, and thus cannot achieve early recognition and alarm functions.

Method used

A smart wearable device was designed, including sensor module, data analysis module, data evaluation module and alarm module. By monitoring temperature, pressure and color data in real time, the temperature change coefficient, pressure change coefficient and color change coefficient are calculated, and the risk index is comprehensively evaluated. , and alarm according to the risk index.

Benefits of technology

It effectively improves the safety and effectiveness of treatment, reduces the occurrence of complications in patients, and reduces the risk of drug extravasation or phlebitis through real-time monitoring and timely intervention.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119073906A_ABST
    Figure CN119073906A_ABST
Patent Text Reader

Abstract

The invention relates to the field of medical recognition, and discloses an intelligent wearable device for early recognition and alarm of phlebitis and drug exosmosis, which is used for solving the problems of phlebitis and drug exosmosis after intravenous infusion or injection. Comprising a device body worn above a venipuncture point and an adjustable fixing band used for fixing the device body, a control system is arranged in the device body, and the control system comprises a sensor module, a data analysis module, a data evaluation module, an alarm module, a communication module, a power module and a display module. The method comprises the following steps: collecting data of a venipuncture part, displaying specific data and a timeline through a display module, analyzing the data to obtain a temperature change coefficient, a pressure change coefficient and a color change coefficient, comprehensively evaluating to obtain a risk index, giving an alarm according to the risk index, sending alarm information to a hospital, and reporting the alarm information to medical staff. The safety and the effect of treatment are effectively improved, and complications of patients are reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical identification, and more specifically to an intelligent wearable device for early identification and alarm of phlebitis and drug extravasation. Background Art

[0002] The phlebitis and drug extravasation identification device is an intelligent medical device designed to identify and warn of possible phlebitis or drug extravasation risks by real-time monitoring of changes in physiological parameters at the puncture site. The device integrates temperature, pressure and color sensors, and with data processing and communication modules, it can capture abnormal situations in a timely manner and send alerts to medical staff, thereby improving the safety and effectiveness of treatment and reducing the occurrence of complications in patients.

[0003] The Chinese patent publication number is: CN111557651A "A kind of automatic identification instrument for venous exudation and phlebitis". Although this automatic identification instrument can realize intelligent diagnosis of venous exudation and phlebitis, it cannot evaluate the condition of punctured veins in real time, and then realize early identification and alarm functions.

[0004] In view of the above problems, the present invention proposes a solution. Summary of the invention

[0005] In order to overcome the above-mentioned defects of the prior art, the present invention provides a smart wearable device for early identification and alarm of phlebitis and drug extravasation to solve the problems existing in the above-mentioned background technology.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] An intelligent wearable device for early identification and alarm of phlebitis and drug extravasation, comprising a device body (1) worn above a venous puncture point and an adjustable fixing belt (2) for fixing the device body, wherein a control system is arranged inside the device body, and the control system comprises:

[0008] The sensor module is used to detect relevant data of the puncture site, including temperature, pressure and color data, and transmit the relevant data to the data analysis module and the communication module;

[0009] A data analysis module is used to receive relevant data transmitted by the sensor module, and process the data to obtain relevant analysis coefficients, wherein the relevant analysis coefficients include temperature variation coefficients, pressure variation coefficients, and color influence coefficients, and transmit the relevant analysis coefficients to the data evaluation module;

[0010] The data evaluation module is used to receive the relevant analysis coefficients transmitted by the data analysis module, conduct comprehensive evaluation to obtain the risk index, and transmit the risk index to the alarm module;

[0011] An alarm module is used to receive the risk index transmitted by the data evaluation module, issue an alarm according to the risk index, and transmit the alarm information to the communication module;

[0012] The communication module is used to receive the relevant data transmitted by the sensor module and transmit the relevant data to the display module; receive the alarm information transmitted by the alarm module, send the alarm information to the hospital intelligent call system, and report it to the medical staff;

[0013] A power module is used to provide power to all electronic components of the smart wearable device, and the power module is a battery;

[0014] The display module includes a display screen connected to the data analysis system and operation buttons on the display screen. The display screen is a touch screen, and the operation buttons can be used to switch between modules and turn the machine on and off.

[0015] Preferably, the step of detecting relevant data of the puncture site is:

[0016] A temperature sensor is set at the puncture site to monitor the temperature change of the puncture site in real time;

[0017] A pressure sensor is arranged at the puncture site to detect the pressure change of the local tissue;

[0018] A color sensor is set at the puncture site, and optical technology is used to detect skin color changes to determine inflammation or extravasation.

[0019] Preferably, the step of processing the data to obtain the correlation analysis coefficient is:

[0020] Calculate the temperature change trend based on the collected real-time temperature data, and calculate the temperature change coefficient based on the temperature change trend and the real-time temperature data;

[0021] Calculate the pressure change trend based on the collected real-time pressure data, and calculate the pressure change coefficient based on the pressure change trend and the real-time pressure data;

[0022] Collecting color data of the puncture area in real time and preprocessing the image, wherein the preprocessing includes color space conversion, noise removal and image enhancement operations;

[0023] The color variation coefficient is calculated based on the preprocessed image analysis.

[0024] Preferably, the temperature variation coefficient calculation step is:

[0025] The temperature data of the puncture site were continuously collected in a time series manner, and the temperature data were smoothed by the sliding average method;

[0026] Collect the temperature data before puncture as the reference temperature;

[0027] The first-order derivative is used to calculate the temperature change trend after puncture, and the calculation formula is: Where Ct represents the temperature change trend at time t, T(t) represents the real-time temperature measured at time t, and represents the temperature of the current puncture site;

[0028] The temperature variation coefficient is calculated based on the difference between the real-time temperature and the reference temperature and the variation trend. The calculation formula is: Where TE is the temperature variation coefficient, T(t) is the real-time temperature measured at time t, and T b Indicated as reference temperature.

[0029] Preferably, the pressure variation coefficient calculation step is:

[0030] The pressure data of the puncture site are continuously collected in a time series manner, and the pressure data are smoothed by a sliding average method;

[0031] Collect the pressure data before puncture as the baseline pressure;

[0032] The first-order derivative is used to calculate the pressure change trend after puncture, and the calculation formula is: Where Cp represents the pressure change trend at time t, P(t) represents the real-time pressure measured at time t, which represents the pressure at the current puncture site;

[0033] The pressure change coefficient is calculated based on the difference between the real-time pressure and the reference pressure and the change trend. The calculation formula is: Where SE is the pressure variation coefficient, P(t) is the real-time pressure measured at time t, and P b Indicated as base pressure.

[0034] Preferably, the step of calculating the color change coefficient based on the pre-processed image analysis is:

[0035] Convert color images from RGB color space to HSV color space;

[0036] Divide the image into n parts equally, record them as sub-images, and extract the saturation data of each sub-image in the HSV color space;

[0037] A saturation threshold is set, the saturation data of each sub-image is compared with the saturation threshold, and the number of sub-images whose saturation data is greater than the saturation threshold is counted as the color change coefficient.

[0038] Preferably, the step of obtaining the risk index through comprehensive evaluation is:

[0039] Normalize the temperature variation coefficient, pressure variation coefficient, and color variation coefficient;

[0040] The risk index is obtained by weighted summing up the normalized temperature variation coefficient, pressure variation coefficient and color variation coefficient. The calculation formula is RI=a1×TE+a2×SE+a3×CE, where RI represents the risk index, TE represents the temperature variation coefficient, SE represents the pressure variation coefficient, CE represents the color variation coefficient, and a1, a2, and a3 represent the weight coefficients of the temperature variation coefficient, the pressure variation coefficient, and the color variation coefficient.

[0041] Preferably, it is characterized in that: the step of issuing an alarm according to the risk index is:

[0042] The risk index is compared with the preset threshold. If the risk index is less than the preset threshold, it is determined that the current risk of phlebitis and drug extravasation is small, and no risk alarm is issued. If the risk index is greater than the preset threshold, it is determined that the current risk of phlebitis and drug extravasation is high, and a risk alarm is issued.

[0043] Technical effects and advantages of the present invention:

[0044] The data of the puncture site is collected, and the specific data and timeline are displayed through the display module. The data is analyzed to obtain the temperature change coefficient, pressure change coefficient and color change coefficient. The risk index is obtained through comprehensive evaluation. An alarm is issued according to the risk index, and the alarm information is sent to the hospital and reported to medical staff, which effectively improves the safety and effectiveness of treatment and reduces the occurrence of complications in patients. BRIEF DESCRIPTION OF THE DRAWINGS

[0045] Figure 1 This is a schematic diagram of the working system of smart wearable devices.

[0046] Figure 2 This is a structural diagram of a smart wearable device.

[0047] Figure 3 Schematic diagram of the hardware system of smart wearable devices. DETAILED DESCRIPTION

[0048] The technical solution of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the present invention. In addition, the forms of the various structures recorded in the following embodiments are merely illustrative. The smart wearable device for early identification and alarm of phlebitis and drug extravasation involved in the present invention is not limited to the various structures recorded in the following embodiments. All other embodiments obtained by ordinary technicians in this field without making creative work belong to the scope of protection of the present invention.

[0049] The present invention provides a smart wearable device for early identification and alarm of phlebitis and drug extravasation, such as Figure 2 As shown, the device comprises a device body (1) worn above the venous puncture point and an adjustable fixing belt (2) for fixing the device body. A control system is arranged inside the device body (1). Figure 3 As shown, the control system includes:

[0050] A sensor module is used to detect relevant data of the puncture site, including temperature, pressure and color data, and transmit the relevant data to the data processing module and the communication module;

[0051] In this embodiment, it should be specifically explained that the steps of detecting the relevant data of the puncture site are:

[0052] A temperature sensor is set at the puncture site to monitor the temperature change of the puncture site in real time. The temperature increase may be a sign of inflammation. The temperature sensor is a device for measuring temperature, which is displayed, recorded and controlled by converting the temperature into an electrical signal;

[0053] A pressure sensor is arranged at the puncture site to detect the pressure change of the local tissue. Drug extravasation may cause abnormal local pressure. The pressure sensor is a device for measuring pressure, which is displayed, recorded and controlled by converting the pressure signal into an electrical signal;

[0054] A color sensor is set at the puncture site to detect skin color changes using optical technology to determine whether there is inflammation or extravasation. The color sensor is a device for detecting and identifying colors. It determines the color of an object by measuring the intensity of different wavelengths of reflected or transmitted light.

[0055] The sensor can monitor the physiological parameters of the puncture site (such as temperature, pressure and color changes) in real time, providing instant data to help detect abnormal conditions early; the collected real-time data can be used to analyze the status of the puncture site and identify abnormal change trends, so that timely intervention measures can be taken; through early identification and intervention of drug extravasation or phlebitis, the negative impact on patients can be reduced, and the treatment effect and patient safety can be improved; real-time monitoring and timely intervention can reduce the discomfort associated with infusion or injection, and improve the patient's comfort and treatment experience.

[0056] A data analysis module is used to receive relevant data transmitted by the sensor module, and process the data to obtain relevant analysis coefficients, wherein the relevant analysis coefficients include temperature variation coefficients, pressure variation coefficients, and color variation coefficients, and transmit the relevant analysis coefficients to the data evaluation module;

[0057] In this embodiment, it should be specifically explained that the step of processing the data to obtain the correlation analysis coefficient is:

[0058] Calculate the temperature change trend based on the collected real-time temperature data, and calculate the temperature change coefficient based on the temperature change trend and the real-time temperature data;

[0059] By calculating the trend of temperature changes, subtle fluctuations in temperature can be detected, which may be early signs of drug extravasation or phlebitis; when drugs extravasate, the drugs enter the surrounding tissues instead of the veins, which may cause local inflammatory reactions. The inflammatory response causes the local tissues to release inflammatory mediators, causing vasodilation and increased blood flow, which leads to local temperature increases; certain drugs (especially those with strong irritants) will cause damage to the surrounding tissues after extravasation, resulting in increased local tissue metabolism, which can also cause temperature increases; phlebitis is an inflammation of the vein wall, and common causes include infection, mechanical stimulation (such as catheters), and chemical stimulation (such as drugs). The inflammatory response causes local vasodilation, increased blood flow, and leukocyte infiltration, resulting in local temperature increases; the body's immune system responds to inflammation and releases various cytokines and inflammatory mediators, which also lead to local temperature increases.

[0060] Calculate the pressure change trend based on the collected real-time pressure data, and calculate the pressure change coefficient based on the pressure change trend and the real-time pressure data;

[0061] When drug extravasation occurs, the drug liquid seeps into the tissue outside the blood vessels, causing fluid accumulation in the local tissue. This accumulation increases the volume of the local tissue, thereby increasing the pressure on the skin and tissue; drug extravasation may cause tissue edema, leading to swelling of the subcutaneous tissue. This swelling will also increase local pressure; drug extravasation may cause an inflammatory response, leading to increased local blood circulation, vasodilation, and increased pressure on local tissues;

[0062] Real-time acquisition of puncture area color data to ensure that the image quality is sufficient for subsequent processing, and preprocessing of the image, including color space conversion, noise removal, and image enhancement operations, to improve the accuracy of subsequent analysis;

[0063] The color variation coefficient is calculated based on the preprocessed image analysis.

[0064] Drug extravasation can cause blood vessels to rupture or be damaged, and blood can seep into the subcutaneous tissue. This can cause local ecchymoses or purple spots on the skin, and the skin color becomes darker; the inflammatory response caused by the drug entering the tissue can cause vasodilation and increased blood flow, causing the local skin to become red. As the inflammatory response develops, the skin color may further darken; irritant drug extravasation can cause local tissue damage, causing the skin color to darken. This is due to the leakage of blood components and the accumulation of hemoglobin degradation products (such as bilirubin) after tissue damage; phlebitis is an inflammation of the vein wall, usually caused by infection, mechanical irritation, or chemical irritation. Inflammation can cause local vasodilation and blood exudation, causing the skin color to become red or purple; phlebitis may cause venous blood flow obstruction, blood stagnation in the veins, and cause local skin color to darken, especially in the area around the veins.

[0065] In this embodiment, it should be specifically explained that the temperature variation coefficient calculation steps are:

[0066] The temperature data of the puncture site were continuously collected in a time series manner, and the temperature data were smoothed by the sliding average method to reduce the impact of noise and sudden changes;

[0067] Collect the temperature data before puncture as the reference temperature;

[0068] The first-order derivative is used to calculate the temperature change trend after puncture, and the calculation formula is: Where Ct represents the temperature change trend at time t, T(t) represents the real-time temperature measured at time t, and represents the temperature of the current puncture site;

[0069] The temperature variation coefficient is calculated based on the difference between the real-time temperature and the reference temperature and the variation trend. The calculation formula is: Where TE is the temperature variation coefficient, T(t) is the real-time temperature measured at time t, and T b Indicated as reference temperature.

[0070] In this embodiment, it should be specifically explained that the pressure variation coefficient calculation steps are:

[0071] The pressure data of the puncture site were collected continuously in a time series manner, and the pressure data were smoothed by the sliding average method to reduce the influence of noise and sudden changes.

[0072] Collect the pressure data before puncture as the baseline pressure;

[0073] The first-order derivative is used to calculate the pressure change trend after puncture, and the calculation formula is: Where Cp represents the pressure change trend at time t, P(t) represents the real-time pressure measured at time t, which represents the pressure at the current puncture site;

[0074] The pressure change coefficient is calculated based on the difference between the real-time pressure and the reference pressure and the change trend. The calculation formula is: Where SE is the pressure variation coefficient, P(t) is the real-time pressure measured at time t, and P b Indicated as base pressure.

[0075] In this embodiment, it should be specifically explained that the step of calculating the color change coefficient based on the pre-processed image analysis is:

[0076] Converting color images from RGB color space to HSV color space helps separate color information from brightness information, making color changes easier to analyze;

[0077] Divide the image into n parts equally, record them as sub-images, and extract the saturation data of each sub-image in the HSV color space;

[0078] A saturation threshold is set to distinguish between inflammation areas and normal areas. The saturation data of each sub-image is compared with the saturation threshold. The number of sub-images whose saturation data is greater than the saturation threshold is counted as the color change coefficient.

[0079] The data evaluation module is used to receive the relevant analysis coefficients transmitted by the data analysis module, conduct comprehensive evaluation to obtain the risk index, and transmit the risk index to the alarm module;

[0080] In this embodiment, it should be specifically explained that the steps of comprehensively evaluating and obtaining the risk index are:

[0081] The temperature variation coefficient, pressure variation coefficient and color variation coefficient are normalized, and the normalized temperature variation coefficient, pressure variation coefficient and color variation coefficient are weighted and summed to obtain the risk index, which is calculated as RI = a1 × TE + a2 × SE + a3 × CE, where RI is the risk index, TE is the temperature variation coefficient, and the larger the temperature variation coefficient, the higher the risk of drug extravasation. The temperature variation coefficient reflects the significant change of the temperature at the puncture site. When the coefficient increases significantly, it usually indicates an increased probability of local inflammation or tissue damage, which may be caused by drug extravasation. Therefore, by real-time monitoring and analysis of the temperature variation coefficient, the risk of drug extravasation can be identified and warned in time, which helps to take intervention measures quickly and reduce the potential damage to patients. SE is the pressure variation coefficient. The larger the pressure variation coefficient, the higher the risk of drug extravasation. The pressure variation coefficient reflects the significant change of the pressure at the puncture site. When the coefficient increases significantly, it usually indicates an increased probability of local tissue fluid exudation, swelling or inflammatory reaction, which may be caused by drug extravasation. Therefore, by real-time monitoring and analysis of the pressure change coefficient, the risk of drug extravasation can be identified and warned in time, which helps medical staff to quickly take intervention measures to avoid further tissue damage and patient discomfort. CE is expressed as a color change coefficient. The larger the color change coefficient, the higher the risk of drug extravasation. The color change coefficient reflects the significant changes in the skin color of the puncture site. When the coefficient increases significantly, it usually indicates an increased probability of local inflammation, blood exudation or tissue damage, which may be caused by drug extravasation. Specifically manifested as skin color turning red, purple or dark, indicating local tissue reaction or damage, a1, a2, and a3 are expressed as weight coefficients of temperature change coefficient, pressure change coefficient, and color change coefficient, and this embodiment does not specifically calculate the specific values ​​of a1, a2, and a3.

[0082] A single physiological parameter may not be sufficient to accurately judge the risk, while the weighted summation method can integrate the effects of temperature, pressure and color changes to provide a more comprehensive risk assessment. By integrating multiple physiological parameters, the system can more effectively filter out accidental fluctuations and noise and reduce the false alarm rate. The risk index after weighted summation can more accurately reflect the actual status of the puncture site and improve the accuracy of risk prediction. The weights can be dynamically adjusted according to the specific situation to adapt to different patients or drug characteristics, thereby improving the flexibility and accuracy of the prediction.

[0083] The risk index after comprehensive evaluation can identify potential risks at an early stage, thereby issuing early warning signals in a timely manner, ensuring that medical staff or patients can take prompt measures. Through accurate risk assessment, medical staff can identify problems earlier, intervene in a timely manner, and reduce the occurrence of complications. The risk index based on weighted summation can be personalized according to the specific circumstances of each patient, thereby improving the pertinence and effectiveness of monitoring. The data recording and trend analysis of the risk index can provide important reference for subsequent treatment and care, and improve long-term management effects.

[0084] An alarm module is used to receive the risk index transmitted by the data evaluation module, issue an alarm according to the risk index, and transmit the alarm information to the communication module;

[0085] In this embodiment, it should be specifically explained that the steps of issuing an alarm according to the risk index are:

[0086] The risk index is compared with the preset threshold. If the risk index is less than the preset threshold, it is determined that the current risk of phlebitis and drug extravasation is small, and no risk alarm is issued. If the risk index is greater than the preset threshold, it is determined that the current risk of phlebitis and drug extravasation is large, and a risk alarm is issued.

[0087] The communication module is used to receive the relevant data transmitted by the sensor module and display the relevant data;

[0088] Receive the alarm information transmitted by the alarm module, send the alarm information to the hospital intelligent call system, and report it to medical staff;

[0089] In this embodiment, it should be specifically explained that the step of displaying the relevant data is:

[0090] The relevant data and the collection time are sent to a mobile phone, and the relevant data is sent to a cloud data server through the mobile phone. The server is used to make a function graph with time as the horizontal axis for the temperature data, color data and pressure data, and then the function graph is sent to the mobile phone, and the temperature data, color data and pressure data are displayed on the mobile phone.

[0091] The power module is used to provide necessary power to all electronic components of the smart wearable device to ensure the normal operation of the device, and the power module is a battery;

[0092] The power module needs to provide stable voltage and current to ensure that the equipment can operate stably under different working conditions and avoid equipment failure or data errors caused by voltage fluctuations;

[0093] Responsible for monitoring and managing the battery status of the device, including battery power monitoring, charging management and battery protection, to ensure efficient and safe use of the battery;

[0094] Through low-power design and power management strategies, the power consumption of the device is optimized, the battery life is extended, the device can work continuously for a long time, and the user's need for frequent charging is reduced;

[0095] When the main power fails, backup power or emergency power is provided to ensure that the equipment can still work normally at critical moments, especially in medical scenarios that require continuous monitoring.

[0096] The display module includes a display screen connected to the data analysis system and operation buttons on the display screen. The display screen is a touch screen, and the operation buttons can be used to switch between modules and turn the machine on and off.

[0097] Through the mobile phone display, patients and medical staff can check the temperature, pressure and color change data of the puncture site at any time to ensure timely understanding of the skin condition. Real-time data updates help to continuously track changes in the puncture site and detect potential problems in a timely manner. When an abnormal situation is detected, the mobile phone can immediately issue an alarm, allowing patients or medical staff to respond quickly and take necessary measures. Medical staff can receive remote notifications through their mobile phones, and can understand the situation and provide guidance in a timely manner even if they are not with the patient. Patients can self-monitor the condition of the puncture site through mobile phone applications to increase their self-management capabilities. Mobile phone applications can provide education and guidance content to help patients understand how to properly deal with abnormal conditions at the puncture site. Real-time monitoring and automatic data recording reduce the manual inspection and recording work of medical staff and improve work efficiency. Medical staff can centrally manage the monitoring data of multiple patients through their mobile phones and allocate resources and time more effectively.

[0098] Finally: The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

[0099] The above is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any person skilled in the art who is familiar with the present technical field can easily think of changes or substitutions within the technical scope disclosed in the present application, which should be included in the protection scope of the present application. Therefore, the protection scope of the present application should be based on the protection scope of the claims.

Claims

1. A smart wearable device for early identification and alarm of phlebitis and drug extravasation. It is characterized in that The device comprises a device body (1) worn above a venous puncture point and an adjustable fixing belt (2) for fixing the device body. A control system is arranged inside the device body, and the control system comprises: A sensor module, used to detect relevant data of the venipuncture site, including temperature, pressure and color data, and transmit the relevant data to the data analysis module and the communication module; A data analysis module is used to receive relevant data transmitted by the sensor module, and process the data to obtain relevant analysis coefficients, wherein the relevant analysis coefficients include temperature variation coefficients, pressure variation coefficients, and color variation coefficients, and transmit the relevant analysis coefficients to the data evaluation module; The data evaluation module is used to receive the relevant analysis coefficients transmitted by the data analysis module, conduct comprehensive evaluation to obtain the risk index, and transmit the risk index to the alarm module; An alarm module is used to receive the risk index transmitted by the data evaluation module, issue an alarm according to the risk index, and transmit the alarm information to the communication module; The communication module is used to receive the relevant data transmitted by the sensor module and transmit the relevant data to the display module; receive the alarm information transmitted by the alarm module, send the alarm information to the hospital intelligent call system, and report it to the medical staff; A power module is used to provide power to all electronic components of the smart wearable device, and the power module is a battery; The display module includes a display screen connected to the data analysis system and operation buttons on the display screen. The display screen is a touch screen, and the operation buttons can be used to switch between modules and turn the machine on and off.

2. According to claim 1, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The steps for detecting the relevant data of the venipuncture site are: A temperature sensor is set at the puncture site to monitor the temperature change of the puncture site in real time; A pressure sensor is arranged at the puncture site to detect the pressure change of the local tissue; A color sensor is set at the puncture site, and optical technology is used to detect skin color changes to determine inflammation or extravasation.

3. According to claim 1, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The steps of processing the data to obtain the correlation analysis coefficient are as follows: Calculate the temperature change trend based on the collected real-time temperature data, and calculate the temperature change coefficient based on the temperature change trend and the real-time temperature data; Calculate the pressure change trend based on the collected real-time pressure data, and calculate the pressure change coefficient based on the pressure change trend and the real-time pressure data; Collecting color data of the puncture area in real time and preprocessing the image, the preprocessing includes color space conversion, noise removal and image enhancement operations; The color variation coefficient is calculated based on the preprocessed image analysis.

4. According to claim 3, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The temperature variation coefficient calculation steps are: The temperature data of the puncture site were continuously collected in a time series manner, and the temperature data were smoothed by the sliding average method; Collect the temperature data before puncture as the reference temperature; The temperature trend after infusion or injection is calculated using the first-order derivative, which is calculated as follows: Where Ct represents the temperature change trend at time t, T(t) represents the real-time temperature measured at time t, and represents the temperature of the current puncture site; The temperature variation coefficient is calculated based on the difference between the real-time temperature and the reference temperature and the variation trend. The calculation formula is: Where TE is the temperature variation coefficient, T(t) is the real-time temperature measured at time t, and T b Indicated as reference temperature.

5. According to claim 3, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The pressure variation coefficient calculation steps are: The pressure data of the puncture site are continuously collected in a time series manner, and the pressure data are smoothed by a sliding average method; Collect the pressure data before puncture as the baseline pressure; The first-order derivative is used to calculate the pressure change trend after puncture, and the calculation formula is: Where Cp represents the pressure change trend at time t, P(t) represents the real-time pressure measured at time t, which represents the pressure at the current puncture site; The pressure change coefficient is calculated based on the difference between the real-time pressure and the reference pressure and the change trend. The calculation formula is: Where SE is the pressure variation coefficient, P(t) is the real-time pressure measured at time t, and P b Indicated as base pressure.

6. According to claim 3, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The step of calculating the color change coefficient based on the pre-processed image analysis is: Convert color images from RGB color space to HSV color space; Divide the image into n parts equally, record them as sub-images, and extract the saturation data of each sub-image in the HSV color space; A saturation threshold is set, the saturation data of each sub-image is compared with the saturation threshold, and the number of sub-images whose saturation data is greater than the saturation threshold is counted as the color change coefficient.

7. According to claim 1, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The steps of obtaining the risk index through comprehensive evaluation are as follows: Normalize the temperature variation coefficient, pressure variation coefficient, and color variation coefficient; The risk index is obtained by weighted summing up the normalized temperature variation coefficient, pressure variation coefficient and color variation coefficient. The calculation formula is RI=a1×TE+a2×SE+a3×CE, where RI represents the risk index, TE represents the temperature variation coefficient, SE represents the pressure variation coefficient, CE represents the color variation coefficient, and a1, a2, and a3 represent the weight coefficients of the temperature variation coefficient, the pressure variation coefficient, and the color variation coefficient.

8. According to claim 1, a smart wearable device for early identification and alarm of phlebitis and drug extravasation, Features: The steps of alarming according to the risk index are as follows: The risk index is compared with the preset threshold. If the risk index is less than the preset threshold, it is determined that the current risk of phlebitis and drug extravasation is small, and no risk alarm is issued. If the risk index is greater than the preset threshold, it is determined that the current risk of phlebitis and drug extravasation is high, and a risk alarm is issued.

Citation Information

Patent Citations

  • Vein exudation and phlebitis automatic identification instrument

    CN111557651A